Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension

Area of Science:

• Cardiovascular Research
• Immunology
• Pulmonary Medicine

Background:

• Pulmonary hypertension (PH) is a severe condition with poor survival rates.
• Inflammation and immune dysregulation are critical in PH development and progression.
• Vascular remodeling in PH is linked to mediator imbalance and altered immune responses.

Purpose of the Study:

• To elucidate the role of inflammatory pathways in pulmonary vascular remodeling and PH.
• To discuss potential therapeutic interventions targeting inflammation in PH.
• To highlight the significance of immune processes in PH pathobiology.

Main Methods:

• Review of current literature on inflammation and immunity in PH.
• Analysis of key inflammatory mediators and cell types involved in vascular lesions.
• Examination of signaling pathways, including bone morphogenic protein receptor 2 (BMPR2).

Main Results:

• Perivascular inflammation is a common feature across all PH types.
• Macrophages, neutrophils, T cells, dendritic cells, and mast cells are implicated.
• Dysfunctional BMPR2 signaling and immune dysregulation promote inflammatory cell accumulation.

Conclusions:

• Inflammatory pathways and immune processes are central to PH pathogenesis.
• Targeting inflammation and immune responses presents promising therapeutic avenues for PH.
• Interventions aimed at resolving inflammation may halt or reverse pulmonary vascular remodeling.